Global Cardiovascular Implants Market Analysis, Industry Size, Share, Growth 2023-2028

The global cardiovascular implants market size reached a value of US$ 24.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 35.6 Billion by 2028, exhibiting at a CAGR of 6.11% during 2023-2028.

Cardiovascular implants refer to devices that support the heart and circulation or help in rhythm control. They are widely used to treat several heart conditions including heart failure, myocardial infarction, and coronary artery diseases. These devices can be divided into two general categories: the ones that function by remaining inside the patient’s body after a surgery, and others that are employed only during the course of the surgery and hospital stay. One of the most popular types of implants is pacemakers, which regulate the heartbeat at a stable pace. These devices are highly reliable and efficient owing to which they are constantly gaining preference across the globe.

Global Cardiovascular Implants Market Trends:

There has been a significant rise in the prevalence of cardiovascular diseases, owing to shifting dietary patterns, inflating disposable income levels and hectic work schedules. This, in confluence with a rapidly growing geriatric population across the globe, is one of the major factors driving the growth of the market. Furthermore, manufacturers are continually investing in research and development (R&D) activities to manufacture safe and efficient variants equipped with advanced technologies. They are introducing smart stent devices, which are anticipated to create a positive outlook for the market. Furthermore, numerous governmental regulations aimed at the improvement of healthcare infrastructure and making quality healthcare services accessible to all are also impelling the demand for these implants.

Request for a free sample copy of this research report: https://www.imarcgroup.com/cardiovascular-implants-market/requestsample

Some of the major players operating in the industry include Biotronik, Abbott Laboratories (ABT), AMG International, B-Braun, Johnson & Johnson, W.L. Gore & Associates, Medtronic, Boston Scientific, Sorin, Edwards Lifesciences, Fortimedix, Neovasc Inc., On-X Life Technologies, Proxy Biomedical, Reva Medical and Shree Pacetronix Ltd.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiovascular implants market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product type, material, procedure type and indication.

Breakup by Product Type:

  • Coronary Stent
  • ICD
  • Heart Valve
  • Implanted Cardiac Pacemaker
  • CRT Device
  • Peripheral Stent

ICD dominates the market as it assists in recording, reporting, and monitoring diseases.

Breakup by Material:

  • Metals and Alloys
  • Polymers
  • Biological Materials

Based on the material, the market has been segmented into metals and alloys, polymers and biological materials.

Breakup by Procedure Type:

  • Angioplasty
  • Open Heart Surgery

Based on the procedure type, the market has been segmented into angioplasty and open-heart surgery.

Breakup by Indication:

  • Arrhythmias
  • Myocardial Ischemia
  • Acute Myocardial Infarction
  • Congestive Heart Failure
  • Others

Arrhythmias exhibit a clear dominance in the market as they facilitate the symptoms of irregular heartbeat and fluttering in the chest.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America holds the majority of the global cardiovascular implants market share due to the well-established healthcare infrastructure in the region.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=1164&flag=C

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are BIOTRONIK SE & Co. KG, Abbott Laboratories, AMG International, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Medtronic Private Limited, Boston Scientific Corporation, Sorin Corporation, Edwards Lifesciences Corporation, Fortimedix Surgical B.V., Neovasc Inc., CryoLife Inc., Proxy Biomedical Ltd., REVA Medical, LLC., and Shree Pacetronix Ltd.

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America holds the majority of the global cardiovascular implants market share due to the well-established healthcare infrastructure in the region.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are BIOTRONIK SE & Co. KG, Abbott Laboratories, AMG International, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Medtronic Private Limited, Boston Scientific Corporation, Sorin Corporation, Edwards Lifesciences Corporation, Fortimedix Surgical B.V., Neovasc Inc., CryoLife Inc., Proxy Biomedical Ltd., REVA Medical, LLC., and Shree Pacetronix Ltd.

Related Reports By IMARC Group

Top 10 Largest Sugar Companies in the World

Top Largest Salmon Producing Companies in Farming Industry

List of Top 10 Oleochemicals Manufacturing Companies In The World

North America Mayonnaise Market Share

Pyridine Market Report

Humidifiers Market Share

Respiratory Diagnostics Market Size

Indian Handicrafts Market Analysis

US Handicrafts Market Trends

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Comment